Official UK procurement notice
NHS England South East - Diabetic Eye Screening Programmes (DESP) across the South East
Authority: NHS England (Central government)·Consortium: 3 public authorities
What is being bought5 lots · detail below
Published requirement descriptionNHS England South East (NHSE) sought to commission a Provider(s) which had the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements.
The procurement was divided into 5 lots within the South East as follows:
Lot 1: Kent and Medway (ICB footprint)
Lot 2: Surrey Heartlands (ICB footprint)
Lot 3: Hampshire and IOW (ICB footprint)
Lot 4: Berkshire (Local Authority) and Frimley (ICB footprint)
Lot 5: Oxfordshire and Buckinghamshire (Local Authority footprint)
Providers were able to bid for one or all Lots.
Contracts are for a term of 5 years, with the option to extend for up to a further 3 years. Services are planned to commence from 1st April 2025.
The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces.
The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy.
This should be achieved by delivering an evidence-based service that:
- focuses on improving uptake, reducing inequalities, and improving outcomes
- is accessible across all service elements
- is engaging, and integrated, working effectively with service users and stakeholders to ensure seamless and high-quality care
- is safe, effective, and high quality, with robust processes along the pathway
- embed a culture of quality, improvement, and learning
- is well-led, managed, and staffed
There are three key elements of service delivery, namely:
- routine digital screening - from 2025 and 2026, all eligible patients are to be managed on 12- or 24-month intervals
- digital surveillance where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required
- slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g., those having cataracts)
Optical Coherence Tomography (OCT) will be introduced into the programme across England in line with national guidance.
The total contract values for the 5 year initial term were advertised as follows:
Lot 1: Kent and Medway - £17,755,303
Lot 2: Surrey Heartlands - £8,084,825
Lot 3: Hampshire and IOW - £16,695,800
Lot 4: Berkshire and Frimley - £11,311,121
Lot 5: Oxfordshire and Buckinghamshire - £9,927,015
This notice serves as an intention to award a contract under the competitive process of the Provider Selection Regime (PSR).
This procurement has been carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners.
CPV: Health services
Lots and requirements (5)Procurement structure
5 lots · all with a published value (£63,774,064 together) · evaluation weights differ by lotLot #1Kent and MedwayAwardedPublished value£17,755,303
NHS England South East (NHSE) sought to commission a Provider(s) which have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements.
Lot 1 covers Kent and Medway and has an eligible population of around 124,000 people.
The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces.
The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy.
This will be achieved by delivering an evidence-based service that:
- Identifies the eligible population and ensured effective delivery with maximum coverage
- Is safe, effective, high quality, externally and independently monitored, and quality assured
- Leads to earlier detection, appropriate referral, effective treatment, and improved outcomes
- Is delivered and supported by suitably trained, competent, and qualified clinical and non-clinical staff who, where relevant, participated in recognised ongoing continuing medical education (CME), continuous professional development (CPD), and quality assurance (QA) schemes
- Has audit embedded in the service
- Works effectively with other stakeholders to ensure the care pathway was smooth and efficient.
There are three key elements of service delivery, namely:
- Routine digital screening - from 2025 and 2026, all eligible patients are managed on 12- or 24-month intervals for routine diabetic eye screening.
- Digital surveillance, where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required.
- Slit lamp bio-microscopy (SLB) for those individuals where normal photography are inappropriate (e.g., those having cataracts).
The Contract is planned to commence on 1st April 2025, for an initial term of 5 years, with the option to extend for a further 3 years.
Lot #2Surrey HeartlandsAwardedPublished value£8,084,825
NHS England South East (NHSE SE) sought to commission a Provider(s) which have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements.
Lot 2 covers Surrey Heartlands and has an eligible population of around 56,000 people.
The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces.
The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy.
This will be achieved by delivering an evidence-based service that:
- Identifies the eligible population and ensured effective delivery with maximum coverage
- Is safe, effective, high quality, externally and independently monitored, and quality assured
- Leads to earlier detection, appropriate referral, effective treatment, and improved outcomes
- Is delivered and supported by suitably trained, competent, and qualified clinical and non-clinical staff who, where relevant, participated in recognised ongoing continuing medical education (CME), continuous professional development (CPD), and quality assurance (QA) schemes
- Has audit embedded in the service
- Works effectively with other stakeholders to ensure the care pathway was smooth and efficient.
There are three key elements of service delivery, namely:
- Routine digital screening - from 2025 and 2026, all eligible patients are managed on 12- or 24-month intervals for routine diabetic eye screening.
- Digital surveillance, where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required.
- Slit lamp bio-microscopy (SLB) for those individuals where normal photography are inappropriate (e.g., those having cataracts).
The Contract is planned to commence on 1st April 2025, for an initial term of 5 years, with the option to extend for a further 3 years.
Lot #3Hampshire and Isle of WightAwardedPublished value£16,695,800
NHS England South East (NHSE) sought to commission a Provider(s) which have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements.
Lot 3 covers the Hampshire and Isle of Wight ICB area and has an eligible population of around 117,000 people.
The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces.
The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy.
This will be achieved by delivering an evidence-based service that:
- Identifies the eligible population and ensured effective delivery with maximum coverage
- Is safe, effective, high quality, externally and independently monitored, and quality assured
- Leads to earlier detection, appropriate referral, effective treatment, and improved outcomes
- Is delivered and supported by suitably trained, competent, and qualified clinical and non-clinical staff who, where relevant, participated in recognised ongoing continuing medical education (CME), continuous professional development (CPD), and quality assurance (QA) schemes
- Has audit embedded in the service
- Works effectively with other stakeholders to ensure the care pathway was smooth and efficient.
There are three key elements of service delivery, namely:
- Routine digital screening - from 2025 and 2026, all eligible patients are managed on 12- or 24-month intervals for routine diabetic eye screening.
- Digital surveillance, where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required.
- Slit lamp bio-microscopy (SLB) for those individuals where normal photography are inappropriate (e.g., those having cataracts).
The Contract is planned to commence on 1st April 2025, for an initial term of 5 years, with the option to extend for a further 3 years.
Lot #4Berkshire & FrimleyAwardedPublished value£11,311,121
NHS England South East (NHSE) sought to commission a Provider(s) which have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements.
Lot 4 covers all of Berkshire and the Frimley ICB area and has an eligible population of around 79,000.
The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces.
The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy.
This will be achieved by delivering an evidence-based service that:
- Identifies the eligible population and ensured effective delivery with maximum coverage
- Is safe, effective, high quality, externally and independently monitored, and quality assured
- Leads to earlier detection, appropriate referral, effective treatment, and improved outcomes
- Is delivered and supported by suitably trained, competent, and qualified clinical and non-clinical staff who, where relevant, participated in recognised ongoing continuing medical education (CME), continuous professional development (CPD), and quality assurance (QA) schemes
- Has audit embedded in the service
- Works effectively with other stakeholders to ensure the care pathway was smooth and efficient.
There are three key elements of service delivery, namely:
- Routine digital screening - from 2025 and 2026, all eligible patients are managed on 12- or 24-month intervals for routine diabetic eye screening.
- Digital surveillance, where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required.
- Slit lamp bio-microscopy (SLB) for those individuals where normal photography are inappropriate (e.g., those having cataracts).
The Contract is planned to commence on 1st April 2025, for an initial term of 5 years, with the option to extend for a further 3 years.
Lot #5Oxfordshire and BuckinghamshireAwardedPublished value£9,927,015
NHS England South East (NHSE) sought to commission a Provider(s) which have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements.
Lot 5 covers the whole of Buckinghamshire and Oxfordshire and has an eligible population of around 69,000 people.
The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces.
The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy.
This will be achieved by delivering an evidence-based service that:
- Identifies the eligible population and ensured effective delivery with maximum coverage
- Is safe, effective, high quality, externally and independently monitored, and quality assured
- Leads to earlier detection, appropriate referral, effective treatment, and improved outcomes
- Is delivered and supported by suitably trained, competent, and qualified clinical and non-clinical staff who, where relevant, participated in recognised ongoing continuing medical education (CME), continuous professional development (CPD), and quality assurance (QA) schemes
- Has audit embedded in the service
- Works effectively with other stakeholders to ensure the care pathway was smooth and efficient.
There are three key elements of service delivery, namely:
- Routine digital screening - from 2025 and 2026, all eligible patients are managed on 12- or 24-month intervals for routine diabetic eye screening.
- Digital surveillance, where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required.
- Slit lamp bio-microscopy (SLB) for those individuals where normal photography are inappropriate (e.g., those having cataracts).
The Contract is planned to commence on 1st April 2025, for an initial term of 5 years, with the option to extend for a further 3 years.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Lots publish different evaluation splits; there is no single procedure weighting.
| Lot | Quality | Social value | Environmental | Split |
|---|---|---|---|---|
| 1 · Kent and Medway | 68% | 13% | 19% | |
| 2 · Surrey Heartlands | 68% | 13% | 19% | |
| 3 · Hampshire and Isle of Wight | 68% | 13% | 19% | |
| 4 · Berkshire & Frimley | 68% | 13% | 19% | |
| 5 · Oxfordshire and Buckinghamshire | 68% | 13% | 19% |
- Technical & professional ability
Details regarding the selection criteria are described within the ITT Bidder Instructions document. This includes details on the economic and financial standing tests that will be managed including the 'pass' score.
Minimum: Minimum level(s) of standards possibly required: (no more than 10,000 characters)
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 15 Jan 2024, 16:42 GMT
- Last source update
- 22 Oct 2024, 09:27 BST
- Award evaluation window
- 5 Jun 2024 – …
- Authority reference
C253273- FTS notice number
2024/S 000-034056- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-042d4eFind a Tender
Publisher note: The decision to award this contract in line with the Competitive Process was based on evaluation against the basic selection criteria (in the form of a Selection Questionnaire), which was assessed on a pass/fail basis, the PSR 5 key criteria, plus staffing and mobilisation, which were assessed on a 0-4 scale, with the below weightings. Several tender questions were asked under each of the key criteria. - Quality and Innovation: 38% - Value: 5% - Integration, Collaboration and Service Sustainability: 19% - Improving Access, Reducing Health Inequalities, and Facilitating Choice: 15% - Social Value: 13% - Staffing and mobiliation: 10% The provider(s) selected for award have been chosen as they passed the basic selection criteria and were the highest scoring bidder overall, against the key criteria. After conducting a thorough Competitive Process, taking into account the key criteria and applying the basic selection criteria, NHS England South East is content that the provider's bids sufficiently met the key criteria and thus can proceed to contract award under the Health Care Services (Provider Selection Regime) Regulations 2023. The evaluation panel consisted of representatives from NHS England South East, including Commissioning, Screening & Immunisations, Finance, Human Resources, and Nursing & Quality. Award decisions have been recommended by the Head of Public Health Commissioning for Hampshire & Thames Valley (NHSE SE), and the Senior Public Health Commissioning Manager (NHSE SE). Award decisions have been made by key members of the South East Regional Executive Team (SERET), namely, the South East Regional Director (also Chair) and the Regional Director of Commissioning for the South East. There were two potential declarations of conflict of interest made via the conflict of interest process and recorded accordingly; these were not decision makers. Conflicts were appropriately managed, with one personnel being removed from the process. The other conflict recorded, upon review, was not deemed as an actual (or perceived conflict). This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by midnight Monday 21st October. This contract has not yet formally been awarded; this notice serves as an intention to award a contract under the competitive process of the PSR. This procurement has been carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners. Written representations should be sent to [email protected]
How it was run
Official notice- Submission deadline
- 5 Jun 2024, 12:00 BST
- Submission channel
- {"written"}
- Accepted languages
- en
- Bid validity
- 180 days from the deadline
- Bids opened
- 5 Jun 2024, 12:15 BST
Timeline
1 Apr 2024 → 22 Oct 2024 · 4 dates- Next notice expected1 Apr 2024, 00:00 BST
- Submission deadline5 Jun 2024, 12:00 BST
- Bids opened5 Jun 2024, 12:15 BST
- Notice published22 Oct 2024, 09:27 BST
Notice history
7 events · 5 releases on Find a Tender · since 15 Apr 2024- Published value updated to £63,774,06415 Apr 2024, 10:09 BSTwas £12,141,372
- Status changed to active15 Apr 2024, 10:09 BST
- Procurement method changed15 Apr 2024, 10:09 BST
- Deadline published: 5 Jun 2024, 12:00 BST15 Apr 2024, 10:09 BST
- Buyer details updated15 Apr 2024, 10:09 BST
- Status changed to complete8 Oct 2024, 14:20 BST
- Buyer details updated8 Oct 2024, 14:20 BST
Published amendments (2 · 0 deadline changes)
| When | What | Before | After | Shift |
|---|---|---|---|---|
| — | TextShort Description · II.1.4 | If you are interested in these services, please register on the e-procurement system, Atamis (details at the end of this notice), and submit a completed provider market engagement questionnaire by 12 noon on 2nd February 2024. | If you are interested in these services, please register on the e-procurement system, Atamis (details at the end of this notice), and submit a completed provider market engagement questionnaire by 12 noon on 9th February 2024. |
The contract award date for these contracts is 22nd October 2024. The contract period for these contracts is 5 years, the contract start date is 1st April 2025 and the contract end date is 31st March 2030. The parties will also have the option to extend the contract for a further 3 years, with mutual agreement The total awarded contract value of the contract are as follows: Lot 1 - Kent and Medway…
1 amendment published without a description.
Routine re-releases (5)
- 2024-01: 2 releases · 15 Jan 2024, 23 Jan 2024
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Lot 1 · Kent and Medway1 award | |||
| InHealth Intelligence Limited | £16,815,307 † | — | Awarded |
| Lot 2 · Surrey Heartlands1 award | |||
| InHealth Intelligence Limited | £7,656,783 † | — | Awarded |
| Lot 3 · Hampshire and Isle of Wight1 award | |||
| InHealth Intelligence Limited | £15,811,901 † | — | Awarded |
| Lot 4 · Berkshire & Frimley1 award | |||
| InHealth Intelligence LimitedBerkshire | £10,712,264 † | — | Awarded |
| Lot 5 · Oxfordshire and Buckinghamshire1 award | |||
| InHealth Intelligence Limited | £9,401,519 † | — | Awarded |
Contracts
Kent and Medway · InHealth Intelligence Limited
- Signed
- 23 Sept 2024
- Value
- £16,815,307
- Status
- active
Surrey Heartlands · InHealth Intelligence Limited
- Signed
- 23 Sept 2024
- Value
- £7,656,783
- Status
- active
Hampshire and Isle of Wight · InHealth Intelligence Limited
- Signed
- 23 Sept 2024
- Value
- £15,811,901
- Status
- active
Berkshire · InHealth Intelligence Limited
- Signed
- 23 Sept 2024
- Value
- £10,712,264
- Status
- active
Oxfordshire and Buckinghamshire · InHealth Intelligence Limited
- Signed
- 23 Sept 2024
- Value
- £9,401,519
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · Kent and Medway | 3bids | — | — | — |
| 2 · Surrey Heartlands | 3bids | — | — | — |
| 3 · Hampshire and Isle of Wight | 3bids | — | — | — |
| 4 · Berkshire & Frimley | 3bids | — | — | — |
| 5 · Oxfordshire and Buckinghamshire | 3bids | — | — | — |
Contracting authority & participating public bodies
2 public bodies on the noticeBidders & participating suppliers
1 commercial party on the notice- InHealth Intelligence LimitedAwarded supplier
Official documents & specifications (1)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria